K. Anji Reddy & family was bornon 1 February 1939 in India. Son of turmeric farmer, K. Anji Reddy' founded $1.9 billion (revenues) generic outfit Dr. Reddy's Laboratories, now run by his son and son-in-law. It formed a partnership in June with Merck Serono, a division of Germany's Merck, to develop cancer drugs. It already has a marketing alliance with GlaxoSmithKline and a joint venture with Fujifilm Corp. to develop and sell generic drugs in Japan. Recently Bristol Myers Squibb sued the company for an alleged patent infringement of a cancer drug. He and other family members transferred the bulk of their stake in the company to a family trust. For the first time, he skipped the company's annual shareholders' meeting last July sparking speculation about his retirement.
Reddy died of cancer on 15 March 2013 at the Apollo Hospital in Hyderabad
The Government of India honoured him with the Padma Shri in 2001 and later with the Padmabhushan for his contribution to the Indian pharmaceutical industry
Reddy's Laboratories, which he established in 1984, and chairman of Dr Reddy's Foundation (DRF), the corporate social responsibility arm of the group, established 1996
(Tech) in Pharmaceuticals and Fine chemicals from the University Department of Chemical Technology of University of Mumbai (now Institute of Chemical Technology, Mumbai), followed by a PhD in chemical engineering from the National Chemical Laboratory, Pune in 1969
Kallam Anji Reddy (1 February 1939 – 15 March 2013) was an Indian entrepreneur in the pharmaceutical industry, the founder-chairman of Dr